Description
Role of lysosomal enzymes cathepsins B and D in neuronal vulnerability: potential implications in Alzheimer's disease pathology
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02018-04-01$742,050
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2018-04-01(start date) | $742,050 | — | Role of lysosomal enzymes cathepsins B and D in neuronal vulnerability: potential implications in Alzheimer's… |
Related records · 4
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (exact legal name match; no business number on file)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 236-2024-2025-Q1-00773 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research | $990,675 | FY2025 |
| 236-2021-2022-Q3-00237 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research | $730,576 | FY2022 |
| 110_2020_2021_Q2_2739 | Natural Sciences and Engineering Research Council of Canada | Conseil de recherches en sciences naturelles et en génie du Canada · Discovery Research | $4,160 | FY2021 |
| 236-2017-2018-Q1-00269 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $680,850 | FY2018 |
Cite as: Glassbox record view · Federal grants & contributions · 236-2017-2018-Q4-00617 · retrieved 2026-11-14.